Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno, et al.
Journal of Gastroenterology (2018) Vol. 53, Iss. 3, pp. 305-353
Open Access | Times Cited: 630

Showing 26-50 of 630 citing articles:

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Katsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 7, pp. 648-657
Closed Access | Times Cited: 59
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study
Shinichiro Shinzaki, Katsuyoshi Matsuoka, Hiroki Tanaka, et al.
Journal of Gastroenterology (2021) Vol. 56, Iss. 6, pp. 560-569
Open Access | Times Cited: 57
Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis
Mengmeng Xu, Ying Kong, Nannan Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid
Wei Li, Le Zhang, Qingbiao Xu, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 1069-1069
Open Access | Times Cited: 52
Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview
Amosy E. M’Koma
Medicina (2022) Vol. 58, Iss. 5, pp. 567-567
Open Access | Times Cited: 52
Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease
Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Siddharth Singh, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 55, Iss. 8, pp. 894-907
Open Access | Times Cited: 51
Balancing Microthrombosis and Inflammation via Injectable Protein Hydrogel for Inflammatory Bowel Disease
Liwen Hong, Gaoxian Chen, Zhengwei Cai, et al.
Advanced Science (2022) Vol. 9, Iss. 20
Open Access | Times Cited: 50
Novel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Disease
Elena González-Lozano, Jorge García-García, Júlio Gálvez, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5296-5296
Open Access | Times Cited: 40
Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management
Yoshihiro Sato, Shingo Tsujinaka, Tomoya Miura, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4154-4154
Open Access | Times Cited: 37
Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer
Zhaoji Pan, Hao Lin, Yanyan Fu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Evolving Trends and Burden of Inflammatory Bowel Disease in Asia, 1990–2019: A Comprehensive Analysis Based on the Global Burden of Disease Study
Xuejie Chen, Xin Xiang, Weitong Xia, et al.
Journal of Epidemiology and Global Health (2023) Vol. 13, Iss. 4, pp. 725-739
Open Access | Times Cited: 28
Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis
Kentaro Kojima, Kenji Watanabe, Mikio Kawai, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 13, pp. 1871-1886
Open Access | Times Cited: 10
Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review
Radostina Alexandrova, Ilia Tsachev, Plamen M. Kirov, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 1021-1040
Open Access | Times Cited: 9
Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity
Agata Anna Cisek, Edyta Szymańska, Aldona Wierzbicka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 673-673
Open Access | Times Cited: 8
Associations of inflammatory cytokines with inflammatory bowel disease: a Mendelian randomization study
Zhaoxiang Song, Xiangyu Li, Jinlin Xie, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
TRPM8 inhibits substance P release from primary sensory neurons via PKA/GSK-3beta to protect colonic epithelium in colitis
Zehua Zhang, Xiaohan Yan, Le Kang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Sustainable agriculture, aquaculture and phytoremediation through freshwater macrophytes: a comprehensive review of mineral uptake, soil health, and water quality dynamics
Lone Rafiya Majeed, Deeplata Sharma, Kuldeep Singh Rautela, et al.
Discover Water (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
A retrospective, observational study to examine the effect of early tumor necrosis factor inhibitor use on rates of surgery for Crohn’s disease in Japan
Tetsuya Ishida
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Role of colonic microbiota in the pathogenesis of ulcerative colitis
Ling-yan Pei, Yu-shi Ke, Huanhu Zhao, et al.
BMC Gastroenterology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 69
Hydroalcoholic extract of Tagetes erecta L. flowers, rich in the carotenoid lutein, attenuates inflammatory cytokine secretion and improves the oxidative stress in an animal model of ulcerative colitis
Marianne Caroline Meurer, Mariéli Mees, Luísa Nathália Bolda Mariano, et al.
Nutrition Research (2019) Vol. 66, pp. 95-106
Closed Access | Times Cited: 67
The connection of circadian rhythm to inflammatory bowel disease
Marie Gombert, Joaquín Carrasco‐Luna, Gonzalo Pin‐Arboledas, et al.
Translational research (2018) Vol. 206, pp. 107-118
Closed Access | Times Cited: 66
Accuracy of Ultrasound for Evaluation of Colorectal Segments in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
Shintaro Sagami, Taku Kobayashi, Yusuke Miyatani, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 5, pp. 908-921.e6
Closed Access | Times Cited: 59
Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
Małgorzata Krzystek‐Korpacka, Radosław Kempiński, Mariusz A. Bromke, et al.
Diagnostics (2020) Vol. 10, Iss. 6, pp. 367-367
Open Access | Times Cited: 57
Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
Lihui Lin, Gaoshi Zhou, Peng Chen, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 54
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
Taku Kobayashi, Satoshi Motoya, Shirô Nakamura, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 6, pp. 429-437
Closed Access | Times Cited: 49

Scroll to top